NCT02191215已完成不适用
Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 442
- 主要终点
- Number of patients with adverse event
研究概览
简要总结
The aim of the Post Marketing Study (PMS) is to evaluate the efficacy and safety profile of nevirapine in the management of the HIV/AIDS in an open environment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosis of HIV/AIDS, no age limits
- •patients could be naïve to treatment or pretreated with other antiretroviral agents
排除标准
- •Patients with known hypersensitivity to nevirapine or any other component of the product
研究组 & 干预措施
Nevirapine (Viramune®)
干预措施: Nevirapine (Viramune®) (Drug)
结局指标
主要结局
Number of patients with adverse event
时间窗: up to 90 days
Change in body weight
时间窗: Baseline, up to 90 days
Change in cluster of differentiation 4 (CD4) cell count
时间窗: Baseline, up to 90 days
Change in viral load (HIV RNA)
时间窗: Baseline, up to 90 days
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Safety Study of Abatacept in SwedenRheumatoid ArthritisNCT01094795Bristol-Myers Squibb92,635
终止
不适用
A Prospective, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral DefectsOsteochondral DefectsNCT01209390TiGenix n.v.8
已完成
不适用
PMCF to Assess Real-life Usage Effectiveness, Safety and Patient Satisfaction of a Range of Hypertonic Seawater-based Decongestant Nasal SpraysURTIAllergic RhinitisNCT06104332Laboratoire de la Mer534
已完成
4 期
Efficacy Trial of a Commercial EV71 VaccineHand, Foot and Mouth DiseaseNCT03903926Sinovac Biotech Co., Ltd15,500
已完成
不适用
Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in ChinaHIV-1 InfectionsNCT01074931Abbott98